Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | PPARG | P37231 | 7/20 | 0.50 |
| ▸ | PPARD | Q03181 | 7/20 | 0.50 |
| ▸ | PPARA | Q07869 | 7/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 5/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | PDE4A | P27815 | 1/20 | 0.50 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4518551 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL4528271 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL4522923 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL1054786 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL4532402 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL4531810 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL4528299 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL4528611 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL4517033 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL4532550 | 1.00 | GPR84 (0.50) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119753852-A | Lithium yttrium fluoride composite crystal and preparation method thereof | 安徽环巢光电科技有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119753852-A | Lithium yttrium fluoride composite crystal and preparation method thereof | 安徽环巢光电科技有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-110650944-B | Silica-based zinc catalysts, their preparation and use in the alkoxycarbonylation of amines | 科思创德国股份有限公司 | 2022-07-19 | — | — | CN | disclosed |
| EP-3625210-B1 | SILICA-BASED ZINC CATALYSTS. THEIR PREPARATION AND USE IN THE ALKOXYCARBONYLATION OF AMINES | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2021-06-23 | — | — | EP | disclosed |
| US-10807084-B2 | Silica-based zinc catalysts, their preparation and use in the alkoxycarbonylation of amines | COVESTRO DEUTSCHLAND AG (DE) | 2020-10-20 | — | — | US | disclosed |
| US-20200147594-A1 | SILICA-BASED ZINC CATALYSTS, THEIR PREPARATION AND USE IN THE ALKOXYCARBONYLATION OF AMINES | COVESTRO DEUTSCHLAND AG (DE) | 2020-05-14 | — | — | US | disclosed |
| EP-3625210-A1 | SILICA-BASED ZINC CATALYSTS. THEIR PREPARATION AND USE IN THE ALKOXYCARBONYLATION OF AMINES | Covestro Deutschland AG (DE) | 2020-03-25 | — | — | EP | disclosed |
| CN-110650944-A | Silica-based zinc catalysts, their preparation and use in the alkoxycarbonylation of amines | 科思创德国股份有限公司 | 2020-01-03 | — | — | CN | disclosed |
| WO-2018210711-A1 | SILICA-BASED ZINC CATALYSTS. THEIR PREPARATION AND USE IN THE ALKOXYCARBONYLATION OF AMINES | COVESTRO DEUTSCHLAND AG (DE) | 2018-11-22 | — | — | WO | disclosed |
| US-20090123516-A1 | DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS-THERAPEUTIC SAMS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2009-05-14 | — | — | US | disclosed |
| WO-2007019478-A2 | DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS - THERAPEUTIC SAMS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200147594-A1 | SILICA-BASED ZINC CATALYSTS, THEIR PREPARATION AND USE IN THE ALKOXYCARBONYLATION OF AMINES | CDYL, ZYX, CXXC4 | GPR84 2817/4885PPARG 4428/4885PPARD 4386/4885 |
| US-10807084-B2 | Silica-based zinc catalysts, their preparation and use in the alkoxycarbonylation of amines | CDYL, ZYX, CXXC4 | GPR84 2817/4885PPARG 4428/4885PPARD 4386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.